Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice

Tafenoquine (TQ), a new synthetic analog of primaquine, has relatively poor bioavailability and associated toxicity in glucose-6-phosphate dehydrogenase (G6PD)-deficient individuals. A microemulsion formulation of TQ (MTQ) with sizes <20 nm improved the solubility of TQ and enhanced the oral bioa...

Descripción completa

Detalles Bibliográficos
Autores principales: Melariri, Paula, Kalombo, Lonji, Nkuna, Patric, Dube, Admire, Hayeshi, Rose, Ogutu, Benhards, Gibhard, Liezl, deKock, Carmen, Smith, Peter, Wiesner, Lubbe, Swai, Hulda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346002/
https://www.ncbi.nlm.nih.gov/pubmed/25759576
http://dx.doi.org/10.2147/IJN.S76317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346002/
https://www.ncbi.nlm.nih.gov/pubmed/25759576
http://dx.doi.org/10.2147/IJN.S76317

Ejemplares similares